title: Transient overexposure of neuregulin 3 during early postnatal development impacts selective behaviors in adulthood.
abstract: Neuregulin 3 (NRG3), a specific ligand for ErbB4 and a neuronal-enriched neurotrophin is implicated in the genetic predisposition to a broad spectrum of neurodevelopmental, neurocognitive and neuropsychiatric disorders, including Alzheimer's disease, autism and schizophrenia. Genetic studies in schizophrenia demonstrate that risk variants in NRG3 are associated with cognitive and psychotic symptom severity, accompanied by increased expression of prefrontal cortical NRG3. Despite our expanding knowledge of genetic involvement of NRG3 in neurological disorders, little is known about the neurodevelopmental mechanisms of risk. Here we exploited the fact that a paralog of NRG3, NRG1, readily penetrates the murine blood brain barrier (BBB). In this study we synthesized the bioactive epidermal growth factor (EGF) domain of NRG3, and using previously validated in-vivo peripheral injection methodologies in neonatal mice, demonstrate that NRG3 successfully crosses the BBB, where it activates its receptor ErbB4 and downstream Akt signaling at levels of bioactivity comparable to NRG1. To determine the impact of NRG3 overexpression during one critical developmental window, C57BL/6 male mice were subcutaneously injected daily with NRG1-EGF, NRG3-EGF or vehicle from postnatal days 2-10. Mice were tested in adulthood using a comprehensive battery of behavioral tasks relevant to neurocognitive and psychiatric disorders. In agreement with previous studies, developmental overexposure to NRG1 induced multiple non-CNS mediated peripheral effects as well as severely disrupting performance of prepulse inhibition of the startle response. In contrast, NRG3 had no effect on any peripheral measures investigated or sensorimotor gating. Specifically, developmental NRG3 overexposure produced an anxiogenic-like phenotype and deficits in social behavior in adulthood. These results provide primary data to support a role for NRG3 in brain development and function, which appears to be distinct from its paralog NRG1. Furthermore we demonstrate how perturbations in NRG3 expression at distinct developmental stages may contribute to the neurological deficits observed in brain disorders such as schizophrenia and autism.
authors.affiliation: Department of Psychiatry, University of Colorado, School of Medicine, Aurora, Colorado, United States of America.
authors.forename: Clare
authors.initials: C
authors.lastname: Paterson
authors.affiliation: Department of Psychiatry, University of Colorado, School of Medicine, Aurora, Colorado, United States of America; Department of Cell and Developmental Biology, University of Colorado, School of Medicine, Aurora, Colorado, United States of America.
authors.forename: Amanda J
authors.initials: AJ
authors.lastname: Law
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001522:Behavior, Animal / Q000187:drug effects*; D001812:Blood-Brain Barrier / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004815:Epidermal Growth Factor / Q000737:chemistry; D006801:Humans; D008297:Male; D008568:Memory / Q000187:drug effects; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D020880:Neuregulins / Q000737:chemistry; D010455:Peptides / Q000008:administration & dosage / Q000138:chemical synthesis / Q000493:pharmacokinetics / Q000494:pharmacology*; D010641:Phenotype; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D011597:Psychomotor Performance / Q000187:drug effects; D066247:Receptor, ErbB-4 / Q000378:metabolism; D013216:Reflex, Startle / Q000187:drug effects; D015398:Signal Transduction / Q000187:drug effects
chemical_list: C486357:NRG3 protein, human; D020880:Neuregulins; D010455:Peptides; D004815:Epidermal Growth Factor; D066247:Receptor, ErbB-4; D051057:Proto-Oncogene Proteins c-akt
references.citation: PLoS Biol. 2005 Aug;3(8):e272
references.pmid: 16026180
references.citation: J Neurochem. 2004 Feb;88(4):965-70
references.pmid: 14756818
references.citation: Cell. 2002 Sep 20;110(6):775-87
references.pmid: 12297050
references.citation: Am J Hum Genet. 2008 Feb;82(2):477-88
references.pmid: 18252227
references.citation: Arch Gen Psychiatry. 2009 Sep;66(9):947-56
references.pmid: 19736351
references.citation: PLoS One. 2011;6(10):e26610
references.pmid: 22028923
references.citation: Cereb Cortex. 2012 Jul;22(7):1520-9
references.pmid: 21878485
references.citation: Genome Res. 2009 Sep;19(9):1579-85
references.pmid: 19506092
references.citation: J Neurosci. 2014 Jan 15;34(3):1051-6
references.pmid: 24431462
references.citation: Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12165-70
references.pmid: 22689948
references.citation: Biol Psychiatry. 2008 Dec 15;64(12):1093-6
references.pmid: 18708184
references.citation: J Neurosci. 2009 Sep 30;29(39):12255-64
references.pmid: 19793984
references.citation: Schizophr Res. 2008 Feb;99(1-3):341-9
references.pmid: 18054201
references.citation: Prog Neurobiol. 2009 Apr;87(4):212-51
references.pmid: 19395337
references.citation: Nature. 1998 May 14;393(6681):169-71
references.pmid: 9603519
references.citation: Mol Psychiatry. 2010 Jun;15(6):637-46
references.pmid: 19546859
references.citation: Transl Psychiatry. 2013 Apr 30;3:e252
references.pmid: 23632456
references.citation: Am J Psychiatry. 2006 Oct;163(10):1760-6
references.pmid: 17012687
references.citation: Mol Psychiatry. 2011 Mar;16(3):307-20
references.pmid: 20142818
references.citation: J Neurosci. 2008 Jul 2;28(27):6872-83
references.pmid: 18596162
references.citation: J Neurosci. 2012 Feb 29;32(9):2988-97
references.pmid: 22378872
references.citation: Int J Neuropsychopharmacol. 2013 Apr;16(3):549-56
references.pmid: 22831755
references.citation: J Neurosci. 2003 Jul 23;23(16):6399-403
references.pmid: 12878679
references.citation: Mol Psychiatry. 2011 Aug;16(8):860-6
references.pmid: 20548296
references.citation: Front Neurosci. 2012 May 04;6:53
references.pmid: 22586359
references.citation: Mol Psychiatry. 2014 Jul;19(7):801-10
references.pmid: 23999525
references.citation: Science. 2008 Apr 25;320(5875):539-43
references.pmid: 18369103
references.citation: J Neurosci. 2007 Mar 14;27(11):2948-57
references.pmid: 17360918
references.citation: Neuron. 2013 Sep 18;79(6):1152-68
references.pmid: 24050403
references.citation: Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15619-24
references.pmid: 20713722
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9562-7
references.pmid: 9275162
references.citation: Exp Cell Res. 2003 Mar 10;284(1):14-30
references.pmid: 12648463
references.citation: J Neurosci. 2011 Jul 20;31(29):10721-31
references.pmid: 21775615
references.citation: Am J Hum Genet. 2003 Sep;73(3):601-11
references.pmid: 12929083
references.citation: Toxicol Sci. 2001 Jul;62(1):80-91
references.pmid: 11399796
references.citation: Dev Psychopathol. 2001 Summer;13(3):419-49
references.pmid: 11523842
references.citation: Neuropsychopharmacology. 1993 Aug;9(1):67-75
references.pmid: 8397725
references.citation: J Comp Neurol. 2004 Apr 26;472(2):156-72
references.pmid: 15048684
references.citation: J Biol Chem. 1998 May 1;273(18):11150-7
references.pmid: 9556602
references.citation: Genes Brain Behav. 2004 Oct;3(5):287-302
references.pmid: 15344922
references.citation: J Neurosci. 2008 Aug 27;28(35):8709-23
references.pmid: 18753372
references.citation: J Cell Sci. 2006 Mar 1;119(Pt 5):898-909
references.pmid: 16478787
references.citation: Am J Hum Genet. 2007 May;80(5):938-47
references.pmid: 17436248
references.citation: Biol Psychiatry. 2014 Oct 15;76(8):648-55
references.pmid: 24703509
references.citation: J Neurosci. 2011 Apr 13;31(15):5699-709
references.pmid: 21490211
references.citation: Mol Psychiatry. 2003 Jan;8(1):19-29
references.pmid: 12556905
references.citation: Neuropharmacology. 2013 Dec;75:223-32
references.pmid: 23871843
references.citation: Neuroscience. 2010 Oct 27;170(3):800-7
references.pmid: 20678553
references.citation: J Neurochem. 2011 Jun;117(6):1066-74
references.pmid: 21517849
references.citation: Oncogene. 2002 Dec 5;21(55):8442-52
references.pmid: 12466964
references.citation: Neuron. 2013 May 22;78(4):644-57
references.pmid: 23719163
references.citation: Transl Psychiatry. 2013 May 28;3:e264
references.pmid: 23715299
references.citation: Am J Hum Genet. 2009 Jan;84(1):21-34
references.pmid: 19118813
references.citation: Neuroreport. 2009 Nov 25;20(17):1523-8
references.pmid: 19829162